NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125C959. A total of 2 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,940,000 | +73.1% | 52,800 | +45.1% | 0.00% | +100.0% |
| Q2 2023 | $3,432,520 | -31.5% | 36,400 | -26.5% | 0.00% | -50.0% |
| Q1 2023 | $5,010,390 | +1997.5% | 49,500 | +2375.0% | 0.00% | – |
| Q4 2022 | $238,880 | -98.8% | 2,000 | -98.9% | 0.00% | -100.0% |
| Q3 2022 | $20,052,000 | +10.8% | 188,800 | +1.7% | 0.01% | +12.5% |
| Q2 2022 | $18,102,000 | – | 185,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 19,200 | $179,000 | 0.00% |
| Citadel Advisors | 16,700 | $156,000 | 0.00% |